Literature DB >> 17472950

Modified constraint-induced therapy in patients with chronic stroke exhibiting minimal movement ability in the affected arm.

Stephen J Page1, Peter Levine.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to determine the efficacy of a reimbursable, outpatient modified constraint-induced therapy (mCIT) protocol administered to subjects with chronic stroke who initially exhibited minimal movement ability in their affected wrists and fingers.
SUBJECTS: The subjects were 4 individuals who had experienced a stroke more than 1 year prior to study entry (mean age [+/-SD]=60.25+/-1.98 years, mean time since stroke=37.5+/-23.2 months).
METHOD: A multiple-baseline, preintervention-postintervention, single-blinded case series design was used. The intervention consisted of structured, 1/2-hour therapy sessions emphasizing affected arm use in valued activities, occurring 3 times per week for 10 weeks. Subjects' less affected arms also were restrained 5 days per week for 5 hours per day during the same 10-week period. The main outcome measures were the Action Research Arm Test (ARAT), the Motor Activity Log (MAL), and the Fugl-Meyer Assessment of Motor Recovery (FM).
RESULTS: The subjects exhibited improvements in use of the more affected arm (+1.9, +1.8, +1.7, and +2.3 for subjects 1 through 4, respectively) and in quality of movement (+1.5, +2.1, +1.63, and +1.9 for subjects 1 through 4, respectively), as measured by the MAL. They also exhibited reduced impairment, as measured by the FM (+5.0, +6.5, +5.5, and +5.0 for subjects 1 through 4, respectively), and increased fine motor skill movement, as measured by the ARAT (+7.5, +7.0, +7.0, and +5.5 for subjects 1 through 4, respectively). DISCUSSION AND
CONCLUSION: The findings demonstrated that mCIT participation was efficacious because it led to increased use of the affected arm and of function and to increased ability to perform valued activities. The subjects reported some new ability to perform some valued activities. These outcomes are significant because few therapies are believed to effectively increase use of the affected arm and function in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17472950     DOI: 10.2522/ptj.20060202

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  6 in total

1.  Prevalence, Effect on Functional Outcome, and Treatment of Sleep-Disordered Breathing in Patients With Subacute Stroke.

Authors:  Daisuke Matsuura; Yohei Otaka; Rie Kamigaichi; Kaoru Honaga; Kunitsugu Kondo; Meigen Liu
Journal:  J Clin Sleep Med       Date:  2019-06-15       Impact factor: 4.062

2.  Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference.

Authors:  Julie K Tilson; Katherine J Sullivan; Steven Y Cen; Dorian K Rose; Cherisha H Koradia; Stanley P Azen; Pamela W Duncan
Journal:  Phys Ther       Date:  2009-12-18

Review 3.  Tailoring Brain Stimulation to the Nature of Rehabilitative Therapies in Stroke: A Conceptual Framework Based on their Unique Mechanisms of Recovery.

Authors:  David A Cunningham; Kelsey A Potter-Baker; Jayme S Knutson; Vishwanath Sankarasubramanian; Andre G Machado; Ela B Plow
Journal:  Phys Med Rehabil Clin N Am       Date:  2015-09-09       Impact factor: 1.784

4.  Effect of segmental muscle vibration on upper extremity functional ability poststroke: A randomized controlled trial.

Authors:  Giuseppe Annino; Anas R Alashram; Alia A Alghwiri; Cristian Romagnoli; Giuseppe Messina; Virginia Tancredi; Elvira Padua; Nicola Biagio Mercuri
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  Constraint-Induced Movement Therapy (CIMT): Current Perspectives and Future Directions.

Authors:  Aimee P Reiss; Steven L Wolf; Elizabeth A Hammel; Erin L McLeod; Erin A Williams
Journal:  Stroke Res Treat       Date:  2012-04-17

6.  Effect of home-based rehabilitation of purposeful activity-based electrical stimulation therapy for chronic stroke survivors: a crossover randomized controlled trial.

Authors:  Seigo Minami; Yoshihiro Fukumoto; Ryuji Kobayashi; Hideaki Aoki; Tomoki Aoyama
Journal:  Restor Neurol Neurosci       Date:  2021       Impact factor: 2.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.